[News Brief] Curie Oncology and Oncoshot Deploy AI to Improve Patient Outcomes in Asia
Curie Oncology, a private oncology network in Southeast Asia, has partnered with health‑tech firm Oncoshot to deploy AI‑powered clinical research…
Press Release
[News Brief] SL Aesthetic Group Expands Portfolio on 22nd Anniversary
SL Aesthetic Group has marked 22 years of operation by expanding its medical services and physical footprint across Singapore and…
[News Brief] Fullerton Health Acquires The ENT Clinic
Fullerton Health has completed the acquisition of The ENT Clinic, a prominent Singapore-based otolaryngology practice, to expand its specialist care…
[News Brief] Sanofi’s Tzield Accepted for Priority Review in the US for Young Children with Stage 2 Type 1 Diabetes
Sanofi has announced that the US Food and Drug Administration (FDA) has accepted for priority review the supplemental biologics licence…
[News Brief] Takeda Releases Phase 3 Data for Zasocitinib in Plaque Psoriasis
Takeda has published results from its Phase 3 clinical trials for Zasocitinib, an oral treatment for moderate-to-severe plaque psoriasis. This…
[News Brief] Lunit and Daiichi Sankyo Partner for AI‑Driven Biomarker Discovery and Translational Oncology Research
Lunit has announced a collaboration with Daiichi Sankyo to advance research in AI‑driven biomarker discovery and translational oncology. This summary…
[News Brief] Linaprazan Glurate Included in China’s National Reimbursement List
Cinclus Pharma Holding AB’s drug linaprazan glurate has been included in China’s 2025 National Reimbursement Drug List (NRDL) ahead of…
[News Brief] Maersk Opens First Bonded Warehouse in North Vietnam
A.P. Moller – Maersk has opened its first own‑licensed bonded warehouse in Northern Vietnam, located at SLP Park, Nam Dinh…
[News Brief] ChemLex Secures USD 45M to Launch Self-Driving Lab in Singapore
ChemLex, an AI-for-science startup, has raised USD 45 million in seed funding to launch a self-driving laboratory for drug discovery…
[News Brief] Hyphens Pharma Out-licenses Cerapro® MED to European Markets
Hyphens Pharma Pte. Ltd. has entered into an out-licensing agreement for its skin barrier cream, Cerapro® MED Skin Barrier Cream,…